查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587545

囊肿纤维化治疗市场规模、份额、趋势分析报告：按药物类别、给药途径、分销管道、地区、细分市场预测，2025-2030

Cystic Fibrosis Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Pancreatic Enzyme Supplements), By Route of Administration (Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

囊肿纤维化治疗市场的成长与趋势

Grand View Research, Inc. 的最新报告显示，预计 2030 年全球囊肿纤维化治疗市场规模将达到 227 亿美元，2025 年至 2030 年复合年增长率为 14.2%。

全球囊肿纤维化（CF）盛行率的上升、主要企业的研发活动以及非营利组织的有利倡议预计将在预测期内提振市场。

CF 盛行率的增加表明对替代疗法的需求不断增加，从而推动市场走高。在这个市场上经营的主要企业正在与非营利组织合作，专注于开拓新型治疗方法的市场。临床研究中的药物包括VX-445 + tezacaftor + ivacaftor、PTI-428、QR-010、AZD5634和POL6014。

地方和国家非营利组织的积极努力是推动成长的关键因素之一。这些倡议确保为 CF 患者提供支持。这些组织支持这些治疗方法的研究和开发工作，并帮助改善这些患者的生活品质。例如，成立于 1986 年的北美囊肿纤维化会议 (NACFC) 为 CF 专业人士提供了一个协作和教育论坛，以共用CF 治疗的研究和开发进展。

囊肿纤维化治疗市场报告亮点

  • 预计 2024 年全球 CF 治疗市场规模将达到 103 亿美元，2025 年至 2030 年复合年增长率预计为 14.2%。
  • 囊性纤维化治疗药物占据市场主导地位，2024年占最大销售份额，为44.0%。这是因为 Orkambi（一种 CF 治疗药物）已获得核准，并且有多种临床实验药物正在研发中。
  • 口服给药的成长推动了市场的成长，由于给药的简便性，口服给药在 2024 年占据最大的销售份额，达到 69.0%。
  • 由于该地区有大量白人人口，北美占据了最大的市场占有率。医疗保健基础设施、报销和非营利组织倡议的改善预计将在预测期内推动市场发展。
  • 主要企业包括艾伯维公司(AbbVie Inc.)、罗氏公司(F. Hoffmann-La Roche Ltd.)、吉利德(Gilead)、诺华公司(Novartis AG)、Vertex Pharmaceuticals Inc.、AIT (Advanced Inhalation Therapies) 、Alaxia、梯瓦製药工业有限公司(Teva Pharmaceutical Industries Ltd)、默克公司(Merck & Co. Inc.) 和Alcresta。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章囊肿纤维化治疗市场变数、趋势、范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章囊肿纤维化治疗市场：药物类业务分析

  • 2024 年及 2030 年药品类别市场占有率
  • 药品类别细分仪表板
  • 2018-2030 年按药物类别分類的市场规模、预测与趋势分析
  • CF处理剂
  • 胰酵素补充品
  • 黏液溶解剂
  • 支气管扩张剂

第五章囊肿纤维化治疗市场：途径途径业务分析

  • 2024 年及 2030市场占有率给药途径途径
  • 途径细分仪表板
  • 2018-2030 年按管理途径的市场规模、预测与趋势分析
  • 口服
  • 吸入

第六章囊肿纤维化治疗市场：通路业务分析

  • 2024 年及 2030 年分销通路市场占有率
  • 分销通路细分仪表板
  • 2018-2030 年按分销管道分類的市场规模、预测与趋势分析
  • 医院药房
  • 零售药房
  • 网路药房

第七章囊肿纤维化治疗市场：区域、估计和趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • AbbVie Inc.
    • F. Hoffmann-La Roche Ltd.
    • Gilead
    • Novartis AG
    • Vertex Pharmaceuticals Incorporated
    • AIT（Advanced Inhalation Therapies）
    • Alaxia
    • Teva Pharmaceutical Industries Ltd.
    • Merck &Co. Inc.
    • Alcresta Therapeutics, Inc.
    • AstraZeneca
Product Code: GVR-1-68038-865-7

Cystic Fibrosis Therapeutics Market Growth & Trends:

The global cystic fibrosis therapeutics market size is estimated to reach USD 22.7 billion by 2030, expanding at a CAGR of 14.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of Cystic Fibrosis (CF) globally, research & development activities undertaken by key players, and favorable initiatives undertaken by nonprofit organizations are expected to boost the market over the forecast period.

The rising prevalence of CF indicates the rising demand for treatment alternatives, thereby uplifting the market. The key players operating in this market in collaboration with nonprofit organizations focus on the development of novel therapeutics for treatment. Some of the drugs that are under clinical studies are VX-445 + tezacaftor + ivacaftor, PTI-428, QR-010, AZD5634, and POL6014.

Favorable initiatives taken by regional and national nonprofit organizations is one of the key factors propelling growth. These initiatives ensure support to CF patients. These organizations aid in research & development activities of these therapeutics and help improve the quality of life of these patients. For instance, North American Cystic Fibrosis Conference (NACFC) was formed in 1986 to provide a collaborative and educational forum to CF professionals to share advances in R&D related to CF therapeutics.

Cystic Fibrosis Therapeutics Market Report Highlights:

  • The global CF therapeutics market size was estimated at USD 10.3 billion in 2024 and is expected to grow at a CAGR of 14.2% from 2025 to 2030
  • CFTR modulators dominated the market and accounted for the largest revenue share of 44.0% in 2024 owing to the approval of CFTR modulator, Orkambi and the presence of various investigational compounds under the pipeline.
  • The growth of oral administration led the market and accounted for the largest revenue share of 69.0% in 2024 due to the ease of administration and convenience
  • North America accounted for the largest market share owing to the presence of Caucasian descents in this region. Improved healthcare infrastructure, reimbursements, and initiatives undertaken by the nonprofit organizations is expected to propel the market over forecast period,
  • The key players include AbbVie Inc., F. Hoffmann-La Roche Ltd.; Gilead, Novartis AG, Vertex Pharmaceuticals Inc., AIT (Advanced Inhalation Therapies), Alaxia, Teva Pharmaceutical Industries Ltd, Merck & Co. Inc., Alcresta Therapeutics Inc., Allergan, and AstraZeneca

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Route of Administration
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cystic Fibrosis Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Cystic Fibrosis Therapeutics Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2030
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
  • 4.4. CFTR Modulators
    • 4.4.1. CFTR Modulators Market, 2018 - 2030 (USD Million)
  • 4.5. Pancreatic Enzyme Supplements
    • 4.5.1. Pancreatic Enzyme Supplements Market, 2018 - 2030 (USD Million)
  • 4.6. Mucolytics
    • 4.6.1. Mucolytics Market, 2018 - 2030 (USD Million)
  • 4.7. Bronchodilators
    • 4.7.1. Bronchodilators Market, 2018 - 2030 (USD Million)

Chapter 5. Cystic Fibrosis Therapeutics Market: Route of Administration Business Analysis

  • 5.1. Route of Administration Market Share, 2024 & 2030
  • 5.2. Route of Administration Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market, 2018 - 2030 (USD Million)
  • 5.5. Inhaled
    • 5.5.1. Inhaled Market, 2018 - 2030 (USD Million)

Chapter 6. Cystic Fibrosis Therapeutics Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 7. Cystic Fibrosis Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamic
      • 7.8.5.2. Regulatory Frameworks
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Cystic Fibrosis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. AbbVie Inc.
      • 8.5.1.1. Company Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. F. Hoffmann-La Roche Ltd.
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Gilead
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Novartis AG
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Vertex Pharmaceuticals Incorporated
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. AIT (Advanced Inhalation Therapies)
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Alaxia
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Teva Pharmaceutical Industries Ltd.
      • 8.5.8.1. Company Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Merck & Co. Inc.
      • 8.5.9.1. Company Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Alcresta Therapeutics, Inc.
      • 8.5.10.1. Company Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. AstraZeneca
      • 8.5.11.1. Company Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Cystic Fibrosis Therapeutics Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 5 Global Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 Global Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 North America Cystic Fibrosis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 9 North America Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 10 North America Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 U.S. Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 12 U.S. Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 13 U.S. Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 Canada Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 15 Canada Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 16 Canada Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Mexico Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 18 Mexico Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 19 Mexico Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Europe Cystic Fibrosis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 22 Europe Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 23 Europe Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 UK Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 25 UK Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 26 UK Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Germany Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 28 Germany Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 29 Germany Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 France Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 31 France Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 32 France Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Italy Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 34 Italy Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 35 Italy Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Spain Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 37 Spain Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 38 Spain Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Norway Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 40 Norway Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 Norway Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Denmark Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 43 Denmark Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 Denmark Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Sweden Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 46 Sweden Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 47 Sweden Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Cystic Fibrosis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 Japan Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Japan Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 54 Japan Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 China Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 56 China Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 57 China Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 India Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 59 India Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 60 India Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61 Australia Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Australia Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Australia Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 South Korea Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 65 South Korea Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 66 South Korea Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 Thailand Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 68 Thailand Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 69 Thailand Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Latin America Cystic Fibrosis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 72 Latin America Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 73 Latin America Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74 Brazil Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 75 Brazil Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 76 Brazil Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 Argentina Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 78 Argentina Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 79 Argentina Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Cystic Fibrosis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84 South Africa Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 85 South Africa Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 86 South Africa Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90 UAE Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 91 UAE Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 92 UAE Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Cystic Fibrosis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Cystic Fibrosis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Cystic Fibrosis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Cystic Fibrosis Therapeutics Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-chain-based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Segment Outlook
  • Fig. 10 Segment Outlook
  • Fig. 11 Competitive landscape
  • Fig. 12 Cystic Fibrosis Therapeutics Market Dynamics
  • Fig. 13 Cystic Fibrosis Therapeutics Market: Porter's Five Forces Analysis
  • Fig. 14 Cystic Fibrosis Therapeutics Market: PESTLE Analysis
  • Fig. 15 Cystic Fibrosis Therapeutics Market: Drug Class Segment Dashboard
  • Fig. 16 Cystic Fibrosis Therapeutics Market: Drug Class Market Share Analysis, 2024 & 2030
  • Fig. 17 CFTR Modulators Market, 2018 - 2030 (USD Million)
  • Fig. 18 Pancreatic Enzyme Supplements Market, 2018 - 2030 (USD Million)
  • Fig. 19 Mucolytics Market, 2018 - 2030 (USD Million)
  • Fig. 20 Bronchodilators Market, 2018 - 2030 (USD Million)
  • Fig. 21 Cystic Fibrosis Therapeutics Market: Route of Administration Segment Dashboard
  • Fig. 22 Cystic Fibrosis Therapeutics Market: Route of Administration Market Share Analysis, 2024 & 2030
  • Fig. 23 Oral Market, 2018 - 2030 (USD Million)
  • Fig. 24 Inhaled Market, 2018 - 2030 (USD Million)
  • Fig. 25 Cystic Fibrosis Therapeutics Market: Distribution Channel Segment Dashboard
  • Fig. 26 Cystic Fibrosis Therapeutics Market: Distribution Channel Market Share Analysis, 2024 & 2030
  • Fig. 27 Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 28 Retail Pharmacies Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 29 Online Pharmacies Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 30 Cystic Fibrosis Therapeutics Market Revenue, by Region
  • Fig. 31 Regional Marketplace: Key Takeaways
  • Fig. 32 Regional Marketplace: Key Takeaways
  • Fig. 33 North America Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Country Dynamics
  • Fig. 35 U.S. Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada Country Dynamics
  • Fig. 37 Canada Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Country Dynamics
  • Fig. 39 Mexico Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Country Dynamics
  • Fig. 42 UK Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany Country Dynamics
  • Fig. 44 Germany Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 45 France Country Dynamics
  • Fig. 46 France Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Country Dynamics
  • Fig. 48 Italy Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain Country Dynamics
  • Fig. 50 Spain Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Country Dynamics
  • Fig. 52 Norway Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden Country Dynamics
  • Fig. 54 Sweden Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark Country Dynamics
  • Fig. 56 Denmark Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Japan Country Dynamics
  • Fig. 59 Japan Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 60 China Country Dynamics
  • Fig. 61 China Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 62 India Country Dynamics
  • Fig. 63 India Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 64 Australia Country Dynamics
  • Fig. 65 Australia Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea Country Dynamics
  • Fig. 67 South Korea Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand Country Dynamics
  • Fig. 69 Thailand Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil Country Dynamics
  • Fig. 72 Brazil Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina Country Dynamics
  • Fig. 74 Argentina Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 75 MEA Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 76 South Africa Country Dynamics
  • Fig. 77 South Africa Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia Country Dynamics
  • Fig. 79 Saudi Arabia Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 80 UAE Country Dynamics
  • Fig. 81 UAE Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait Key Country Dynamics
  • Fig. 83 Kuwait Cystic Fibrosis Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 84 Company categorization
  • Fig. 85 Company market position analysis
  • Fig. 86 Strategic framework